Literature DB >> 11229774

Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).

M J Fray1, R P Dickinson.   

Abstract

Structure activity relationships are described for a series of succinyl hydroxamic acids 4a-o as potent and selective inhibitors of matrix metalloprotease-3 (stromelysin-1). Optimisation of P1' and P3' groups gave compound 4j (MMP-3 IC50=5.9nM) which was >140-fold less potent against MMP-1 (IC50=51,000nM), MMP-2 (IC50=1790nM), MMP-9 (IC50=840nM) and MMP-14 (IC50=1900nM).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11229774     DOI: 10.1016/s0960-894x(00)00720-4

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

Review 1.  Targeting matrix metalloproteinase activity and expression for the treatment of viral myocarditis.

Authors:  Reid G Hendry; Leanne M Bilawchuk; David J Marchant
Journal:  J Cardiovasc Transl Res       Date:  2014-01-01       Impact factor: 4.132

2.  Pharmacological Inhibition of MMP3 as a Potential Therapeutic Option for COVID-19 Associated Acute Respiratory Distress Syndrome.

Authors:  Rana Kadry; Andrea Sikora Newsome; Payaningal R Somanath
Journal:  Infect Disord Drug Targets       Date:  2021

3.  Nestin depletion induces melanoma matrix metalloproteinases and invasion.

Authors:  Chung-Wei Lee; Qian Zhan; Cecilia Lezcano; Markus H Frank; John Huang; Allison R Larson; Jennifer Y Lin; Marilyn T Wan; Ping-I Lin; Jie Ma; Sonja Kleffel; Tobias Schatton; Christine G Lian; George F Murphy
Journal:  Lab Invest       Date:  2014-11-03       Impact factor: 5.662

4.  Senescence-associated tissue microenvironment promotes colon cancer formation through the secretory factor GDF15.

Authors:  Yuna Guo; Jessica L Ayers; Kelly T Carter; Ting Wang; Sean K Maden; Darwin Edmond; Polly Newcomb P; Christopher Li; Cornelia Ulrich; Ming Yu; William M Grady
Journal:  Aging Cell       Date:  2019-08-06       Impact factor: 9.304

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.